Approval · Notice of Compliance 12705 · 2011
TRELSTAR: Notice of Compliance 12705
Issued October 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12705
- Date
- October 14, 2011
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Lteinizing Hormone-releasing Hormone (LHRH) Analog
Products in this notice
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per VIAL
- TRIPTORELIN PAMOATE 11.25 MG per VIAL